FDA Inspection 1280989 — Idaho Center for Reproductive Medicine

Idaho Center for Reproductive Medicine — FEI 3007327551

The FDA completed an inspection of Idaho Center for Reproductive Medicine on August 29, 2025 in Boise, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 29, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Boise, ID (United States)